Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for improving chronic lung disease in neonates
IRCT20160102025811N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in bronchopulmonary dysplasia (BPD), sponsored by Tabriz University of Medical Sciences. Started Jul 2018; status: completed.
02
Drugs
sildenafil
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20160102025811N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160102025811N4.